Literature DB >> 26957990

Tryptophan-induced pathogenesis of breast cancer.

Zhu-Gen Cao1, Xiao-Bing Qin2, Fang-Fang Liu3, Lei-Lei Zhou4.   

Abstract

BACKGROUND: The pathogenesis of breast cancer remains unclear. AIMS: To investigate the pathogenesis of breast cancer through targeted metabolomics of amino acids components in serum of patients with breast cancer.
METHODS: Patients with breast cancers were enrolled in our hospital between year January 1(st), 2013 and December 31(st), 2014. Targeted analysis of amino acids was performed using ESI-QTOF-MS instrument. In vitro experiment was performed to determine the influence of tryptophan towards interleukin-10 (IL-10) secretion by CD4+ T cell.
RESULTS: Targeted metabolomics of amino acids showed that the level of tryptophan significantly (p<0.05) increased in patients with breast cancer. Furthermore, the biological function of tryptophan was determined through determining the influence of tryptophan towards IL-10 secretion using in vitro method. The addition of tryptophan (100 uM) in the cell medium can significantly inhibited the secretion of IL-10 by CD4+ T cells, as indicated by the mRNA level and protein concentration.
CONCLUSION: The inhibition of IL-10 secretion by CD4+ T cells is a potential pathogenesis of breast cancer.

Entities:  

Keywords:  T cell; breast cancer; interleukin-10 (IL-10); pathogenesis

Mesh:

Substances:

Year:  2015        PMID: 26957990      PMCID: PMC4765441          DOI: 10.4314/ahs.v15i3.36

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  9 in total

Review 1.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  LC-MS-based metabolomics: an update.

Authors:  Zhong-Ze Fang; Frank J Gonzalez
Journal:  Arch Toxicol       Date:  2014-04-08       Impact factor: 5.153

3.  A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer.

Authors:  Louisa S Chard; Eleni Maniati; Pengju Wang; Zhongxian Zhang; Dongling Gao; Jiwei Wang; Fengyu Cao; Jahangir Ahmed; Margueritte El Khouri; Jonathan Hughes; Shengdian Wang; Xiaozhu Li; Bela Denes; Istvan Fodor; Thorsten Hagemann; Nicholas R Lemoine; Yaohe Wang
Journal:  Clin Cancer Res       Date:  2014-11-21       Impact factor: 12.531

4.  Interleukin-10 (IL-10) promoter genotypes are associated with lung cancer risk in Taiwan males and smokers.

Authors:  Te-Chun Hsia; Wen-Shin Chang; Shinn-Jye Liang; Wei-Chun Chen; Chih-Yen Tu; Hung-Jen Chen; Mei-Due Yang; Chia-Wen Tsai; Chin-Mu Hsu; Chang-Hai Tsai; Da-Tian Bau
Journal:  Anticancer Res       Date:  2014-12       Impact factor: 2.480

5.  Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

Authors:  Changtao Jiang; Cen Xie; Fei Li; Limin Zhang; Robert G Nichols; Kristopher W Krausz; Jingwei Cai; Yunpeng Qi; Zhong-Ze Fang; Shogo Takahashi; Naoki Tanaka; Dhimant Desai; Shantu G Amin; Istvan Albert; Andrew D Patterson; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

6.  Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Authors:  Mohammad-Ali Jenabian; Mohamed El-Far; Kishanda Vyboh; Ido Kema; Cecilia T Costiniuk; Rejean Thomas; Jean-Guy Baril; Roger LeBlanc; Cynthia Kanagaratham; Danuta Radzioch; Ossama Allam; Ali Ahmad; Bertrand Lebouché; Cécile Tremblay; Petronela Ancuta; Jean-Pierre Routy
Journal:  J Infect Dis       Date:  2015-01-23       Impact factor: 5.226

7.  RNA-based TWIST1 inhibition via dendrimer complex to reduce breast cancer cell metastasis.

Authors:  James Finlay; Cai M Roberts; Gina Lowe; Joana Loeza; John J Rossi; Carlotta A Glackin
Journal:  Biomed Res Int       Date:  2015-02-11       Impact factor: 3.411

8.  The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.

Authors:  Yongguo Shi; Juan Li; Yangchen Liu; Jie Ding; Yingrui Fan; Yun Tian; Li Wang; Yifan Lian; Keming Wang; Yongqian Shu
Journal:  Mol Cancer       Date:  2015-02-22       Impact factor: 27.401

9.  Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation.

Authors:  Limin Zhang; Robert G Nichols; Jared Correll; Iain A Murray; Naoki Tanaka; Philip B Smith; Troy D Hubbard; Aswathy Sebastian; Istvan Albert; Emmanuel Hatzakis; Frank J Gonzalez; Gary H Perdew; Andrew D Patterson
Journal:  Environ Health Perspect       Date:  2015-03-13       Impact factor: 9.031

  9 in total
  3 in total

1.  Metabolomic Analysis of Plasma from Breast Cancer Patients Using Ultra-High-Performance Liquid Chromatography Coupled with Mass Spectrometry: An Untargeted Study.

Authors:  Patricia A Da Cunha; Diana Nitusca; Luisa Matos Do Canto; Rency S Varghese; Habtom W Ressom; Shawna Willey; Catalin Marian; Bassem R Haddad
Journal:  Metabolites       Date:  2022-05-17

2.  Combined Analysis of ChIP Sequencing and Gene Expression Dataset in Breast Cancer.

Authors:  Pengfei Liu; Wenhua Jiang; Shiyong Zhou; Jun Gao; Huilai Zhang
Journal:  Pathol Oncol Res       Date:  2016-09-21       Impact factor: 3.201

Review 3.  Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights.

Authors:  Sheetal Parida; Dipali Sharma
Journal:  Cells       Date:  2020-04-28       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.